Matthew G. Cyr

Also affiliated with National Center for Advancing Translational Sciences

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Siglec-6 is a target for chimeric antigen receptor T-cell treatment of chronic lymphocytic leukemia”.

Siglec-6 is a target for chimeric antigen receptor T-cell treatment of chronic lymphocytic leukemia

Leukemia(2021)10.1038/s41375-021-01188-3

N/A

0.483DataRank · unranked

24 citations

Jeong Heon Yoon, Matthew G. Cyr, Samantha Simon, Elisaveta Voynova, Christoph Rader +5 more

Patient-derived Siglec-6-targeting antibodies engineered for T-cell recruitment have potential therapeutic utility in chronic lymphocytic leukemia

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2022-004850

N/A

0.474DataRank · unranked

10 citations

Maissa Mhibik, Junpeng Qi, Haiyong Peng, Chang Jing, Erika M. Gaglione +9 more

Concerted Antibody and Antigen Discovery by Differential Whole-cell Phage Display Selections and Multi-omic Target Deconvolution

Journal of Molecular Biology(2023)10.1016/j.jmb.2023.168085

N/A

0DataRank · unranked

4 citations

Henry D. Wilson, Anna-Lena Spierling, Chang Jing, Haiyong Peng, Peter Steinberger +2 more

Siglec-6 as a therapeutic target for cell migration and adhesion in chronic lymphocytic leukemia

Nature Communications(2024)10.1038/s41467-024-48678-3

N/A

0DataRank · unranked

12 citations

Rakeb Tafesse, Charlene Mao, Matthew Purcell, Xiaokui Mo, Liwen Zhang +5 more